Ex Vivo Production of Platelets from Stem Cells|
There has been initial success in ex vivo generation of platelets from stem cells using cord blood stem cells, embryonic stem cells and induced pluripotent stem cells. However, the platelet yields achieved by these strategies have not been sufficient for clinical purposes. This review provides updated information about the current strategies of ex vivo generation of platelets. [Br J Haematol]
Visit our reviews page to see a complete list of reviews in the cord blood research field.
Cesca Therapeutics Inc., Formerly ThermoGenesis Corp., Closes Merger with TotipotentRX Corporation and Changes Name|
Cesca Therapeutics Inc. announced that it consummated the merger with TotipotentRX Corporation for approximately 12,490,800 shares of the company’s common stock, as contemplated by the previously announced Agreement and Plan of Reorganization. [Cesca Therapeutics Inc.]
STC Life Co., Ltd. Successfully Treats Patients with Parkinson’s Disease at Stem Cell Research and Treatment Center
Stem cell research institute of STC Life Co., Ltd. and 97.7 B&H Clinic successfully completed mesenchymal stem cell therapy for the patients with Parkinson’s disease. Mesenchymal stem cells, one of the adult stem cells, are used a lot for neogenesis, and the stem cell research institute of STC Life Co., Ltd. used stem cells separated from the umbilical cord of fetus. [Business Wire]
From our sponsor: Free mouse hematopoietic progenitors wallchart. Request your copy.